When we have a guest like “Shark Tank” star Mark Cuban, it can be hard to keep up with all his thoughts. He was a bundle of energy in November 2022 explaining his then-new venture trying to reform how Americans can purchase lower-priced drugs; he called it “dunking on the pharma industry.” Since our conversation, experts say Cuban has become a major disrupter in generic drug pricing. Cost Plus now offers 2,500 drugs and has signed up a large list of health systems.

Join us for this encore presentation as hosts Mark Masselli and Margaret Flinter ask Cuban to explain how his approach also includes introducing transparency to drug pricing.